Skip to main navigation
X4 Pharmaceuticals
  • About
  • our medicine
  • science & pipeline
  • Patients
  • healthcare professionals
  • Investors
    • Company Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • SEC Filings
    • Investor FAQs
  • Careers
X4 Pharmaceuticals X4 Pharmaceuticals
  • About
  • our medicine
  • science & pipeline
  • Patients
  • healthcare professionals
  • Investors
    • Company Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • SEC Filings
    • Investor FAQs
  • Careers

News Releases

January 13, 2025
PDF Version
X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand

quick links

Quick Links

  • About
  • Patients
  • Investors
  • Careers
footer logo

contact

X4 Pharmaceuticals
61 North Beacon Street
4th Floor
Boston, MA 02134 Phone: 857.529.8300

X4 Pharmaceuticals (Austria) GmbH
Helmut-Qualtinger-Gasse 2
A-103 Vienna, Austria Phone: +43.1.395078300
© 2025 X4 Pharmaceuticals, Inc. All rights reserved.  

Live - Footer

Terms of Use | Privacy | Compliance and Ethics